UNSPSC 51241107: Dorzolamide

This classification denotes a carbonic anhydrase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9JDX055TW1. European Medicines Agency schedules Dorzolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06374MIG. Dorzolamide generally arises in the molecular formula C10H16N2O4S3.

UNSPSC 51241107 Dorzolamide, a Commodity code, encompasses pharmaceutical supply agreements under which state and local health systems and cooperative purchasing alliances procure branded and generic ophthalmic medications—specifically dorzolamide and similar carbonic anhydrase inhibitors used to treat glaucoma and ocular hypertension. State and local governments buy these products through cooperative purchasing vehicles that consolidate demand across multiple jurisdictions, negotiating volume pricing and ensuring supply chain compliance with FDA and Drug Supply Chain Security Act requirements. Issuing bodies include state departments of administration, multistate cooperative purchasing alliances, and health authorities acting on behalf of participating hospital systems, clinics, and correctional facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary recent buyer activity under this code.

MMCAP issued an RFP on January 20, 2026, due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota, Oregon, and other member jurisdictions. The solicitation required vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC), certify cGMP compliance, maintain contractual relationships with at least two of the three wholesalers with chargeback systems in place, and submit pricing in formats including flat price, net price (NF30, NF60, NF90), or WAC-minus structures. Evaluation weighted price competitiveness at 75 percent, fixed pricing at 10 percent, and compliance with administrative, EDI, and fee requirements at 15 percent combined. Contract awards, effective July 1, 2026, carry a two-year initial term with optional extensions, and vendors must carry $5 million in general liability coverage, $2 million in network security and privacy liability, and $2 million in professional liability insurance.